BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1378 related articles for article (PubMed ID: 33706067)

  • 1. Why blood group A individuals are at risk whereas blood group O individuals are protected from SARS-CoV-2 (COVID-19) infection: A hypothesis regarding how the virus invades the human body via ABO(H) blood group-determining carbohydrates.
    Arend P
    Immunobiology; 2021 May; 226(3):152027. PubMed ID: 33706067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early ovariectomy reveals the germline encoding of natural anti-A- and Tn-cross-reactive immunoglobulin M (IgM) arising from developmental O-GalNAc glycosylations. (Germline-encoded natural anti-A/Tn cross-reactive IgM).
    Arend P
    Cancer Med; 2017 Jul; 6(7):1601-1613. PubMed ID: 28580709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABO (histo) blood group phenotype development and human reproduction as they relate to ancestral IgM formation: A hypothesis.
    Arend P
    Immunobiology; 2016 Jan; 221(1):116-27. PubMed ID: 26433867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Position of human blood group O(H) and phenotype-determining enzymes in growth and infectious disease.
    Arend P
    Ann N Y Acad Sci; 2018 Aug; 1425(1):5-18. PubMed ID: 29754430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABO phenotype-protected reproduction based on human specific α1,2 L-fucosylation as explained by the Bombay type formation.
    Arend P
    Immunobiology; 2018 Nov; 223(11):684-693. PubMed ID: 30075871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosylation is a key in SARS-CoV-2 infection.
    Reis CA; Tauber R; Blanchard V
    J Mol Med (Berl); 2021 Aug; 99(8):1023-1031. PubMed ID: 34023935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABO blood group IgM isoagglutinins interact with tumor-associated O-glycan structures in pancreatic cancer.
    Hofmann BT; Stehr A; Dohrmann T; Güngör C; Herich L; Hiller J; Harder S; Ewald F; Gebauer F; Tachezy M; Precht C; Izbicki JR; Bockhorn M; Wagener C; Wolters-Eisfeld G
    Clin Cancer Res; 2014 Dec; 20(23):6117-26. PubMed ID: 25320359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of the SARS-CoV-2 S-Protein Glycosylation in the Interaction of SARS-CoV-2/ACE2 and Immunological Responses.
    Ramírez Hernández E; Hernández-Zimbrón LF; Martínez Zúñiga N; Leal-García JJ; Ignacio Hernández V; Ucharima-Corona LE; Pérez Campos E; Zenteno E
    Viral Immunol; 2021 Apr; 34(3):165-173. PubMed ID: 33605822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary innate (anti-A-specific) IgM emerging from ontogenic O-GalNAc-transferase depletion: (Innate IgM complementarity residing in ancestral antigen completeness).
    Arend P
    Immunobiology; 2014 Apr; 219(4):285-91. PubMed ID: 24290972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.
    Kim CH
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Glycosylation and Disulfide Bonding of Wild-Type SARS-CoV-2 Spike Glycoprotein.
    Zhang S; Go EP; Ding H; Anang S; Kappes JC; Desaire H; Sodroski JG
    J Virol; 2022 Feb; 96(3):e0162621. PubMed ID: 34817202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABO blood group and COVID-19: a review on behalf of the ISBT COVID-19 Working Group.
    Goel R; Bloch EM; Pirenne F; Al-Riyami AZ; Crowe E; Dau L; Land K; Townsend M; Jecko T; Rahimi-Levene N; Patidar G; Josephson CD; Arora S; Vermeulen M; Vrielink H; Montemayor C; Oreh A; Hindawi S; van den Berg K; Serrano K; So-Osman C; Wood E; Devine DV; Spitalnik SL;
    Vox Sang; 2021 Sep; 116(8):849-861. PubMed ID: 33578447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
    Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
    Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 pseudovirus infectivity and expression of viral entry-related factors ACE2, TMPRSS2, Kim-1, and NRP-1 in human cells from the respiratory, urinary, digestive, reproductive, and immune systems.
    Zhang F; Li W; Feng J; Ramos da Silva S; Ju E; Zhang H; Chang Y; Moore PS; Guo H; Gao SJ
    J Med Virol; 2021 Dec; 93(12):6671-6685. PubMed ID: 34324210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
    Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
    J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2.
    Shajahan A; Archer-Hartmann S; Supekar NT; Gleinich AS; Heiss C; Azadi P
    Glycobiology; 2021 May; 31(4):410-424. PubMed ID: 33135055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
    Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
    Elife; 2022 Jan; 11():. PubMed ID: 35072628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic landscape mapping of humoral immunity to SARS-CoV-2 identifies non-structural protein antibodies associated with the survival of critical COVID-19 patients.
    Cheng L; Zhang X; Chen Y; Wang D; Zhang D; Yan S; Wang H; Xiao M; Liang T; Li H; Xu M; Hou X; Dai J; Wu X; Li M; Lu M; Wu D; Tian R; Zhao J; Zhang Y; Cao W; Wang J; Yan X; Zhou X; Liu Z; Xu Y; He F; Li Y; Yu X; Zhang S
    Signal Transduct Target Ther; 2021 Aug; 6(1):304. PubMed ID: 34404759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19.
    Yadav R; Chaudhary JK; Jain N; Chaudhary PK; Khanra S; Dhamija P; Sharma A; Kumar A; Handu S
    Cells; 2021 Apr; 10(4):. PubMed ID: 33917481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 69.